|
1381 |
Mehr als nur die PAVK im Blick
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 26.9.2017, Nr. 16, date:9.2017: 10-11
|
|
|
|
1382 |
Meta-research metrics matter: letter regarding article “indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease”
Enthalten in Journal of Clinical Movement Disorders Bd. 4, 22.11.2017, Nr. 1, date:12.2017: 1-3
|
|
|
|
1383 |
Methodological Aspects in Studies Based on Clinical Routine Data
Enthalten in Advances in therapy Bd. 34, 12.9.2017, Nr. 10, date:10.2017: 2199-2209
|
|
|
|
1384 |
Methylprednisolone
Enthalten in Reactions weekly Bd. 1686, 27.1.2018, Nr. 1, date:1.2018: 247
|
|
|
|
1385 |
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
Enthalten in Acta diabetologica Bd. 54, 27.7.2017, Nr. 10, date:10.2017: 933-941
|
|
|
|
1386 |
Migräneprophylaxe durch CGRP-Signalweg-Blockade in Phase-III-Studie bestätigt
Enthalten in Schmerzmedizin Bd. 34, 22.1.2018, Nr. 1, date:2.2018: 12
|
|
|
|
1387 |
Migränetherapie: Placeboeffekt nutzen, Noceboeffekt kennen!
Enthalten in Der Neurologe & Psychiater Bd. 18, 3.10.2017, Nr. 9-10, date:10.2017: 18
|
|
|
|
1388 |
Mineralocorticoid Receptor Blockade in End-Stage Renal Disease
Enthalten in Current hypertension reports Bd. 19, 27.4.2017, Nr. 5, date:5.2017: 1-11
|
|
|
|
1389 |
Minimal sufficient balance randomization for sequential randomized controlled trial designs: results from the ESCAPE trial
Enthalten in Trials Bd. 18, 2.11.2017, Nr. 1, date:12.2017: 1-6
|
|
|
|
1390 |
Mitteilungen des BDE
Enthalten in Der Diabetologe Bd. 13, 26.4.2017, Nr. 3, date:5.2017: 222-225
|
|
Administration
